| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 29 | 2025 | 2045 | 1.860 |
Why?
|
| Brain Neoplasms | 43 | 2025 | 9071 | 1.860 |
Why?
|
| Genomics | 42 | 2024 | 5924 | 1.840 |
Why?
|
| Glioma | 26 | 2025 | 3493 | 1.680 |
Why?
|
| Genome, Human | 33 | 2024 | 4446 | 1.640 |
Why?
|
| Gene Dosage | 22 | 2020 | 1213 | 1.600 |
Why?
|
| Aneuploidy | 6 | 2023 | 578 | 1.520 |
Why?
|
| Neoplasms | 50 | 2025 | 22345 | 1.460 |
Why?
|
| Glioblastoma | 29 | 2024 | 3459 | 1.360 |
Why?
|
| Meningioma | 16 | 2022 | 1222 | 1.300 |
Why?
|
| Meningeal Neoplasms | 16 | 2022 | 1253 | 1.120 |
Why?
|
| Genomic Structural Variation | 4 | 2020 | 81 | 1.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 41 | 2025 | 8603 | 0.970 |
Why?
|
| Gene Amplification | 20 | 2025 | 1089 | 0.970 |
Why?
|
| Loss of Heterozygosity | 7 | 2020 | 663 | 0.930 |
Why?
|
| Mutation | 67 | 2025 | 30184 | 0.920 |
Why?
|
| Chromosome Aberrations | 12 | 2018 | 1774 | 0.890 |
Why?
|
| Software | 7 | 2022 | 4459 | 0.880 |
Why?
|
| Oncogenes | 15 | 2023 | 1232 | 0.820 |
Why?
|
| Azepines | 4 | 2019 | 327 | 0.810 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2023 | 2839 | 0.770 |
Why?
|
| Medulloblastoma | 5 | 2019 | 657 | 0.770 |
Why?
|
| Genes, Essential | 3 | 2020 | 185 | 0.740 |
Why?
|
| Cell Line, Tumor | 66 | 2025 | 17062 | 0.730 |
Why?
|
| Astrocytoma | 3 | 2019 | 772 | 0.650 |
Why?
|
| Genetics, Population | 2 | 2021 | 943 | 0.650 |
Why?
|
| High-Throughput Nucleotide Sequencing | 17 | 2022 | 3651 | 0.640 |
Why?
|
| Triazoles | 4 | 2019 | 897 | 0.640 |
Why?
|
| Evolution, Molecular | 6 | 2020 | 1888 | 0.620 |
Why?
|
| INDEL Mutation | 3 | 2020 | 268 | 0.620 |
Why?
|
| Neural Stem Cells | 3 | 2020 | 898 | 0.590 |
Why?
|
| Genes, Tumor Suppressor | 12 | 2023 | 1059 | 0.580 |
Why?
|
| Sequence Deletion | 3 | 2018 | 1493 | 0.560 |
Why?
|
| Cell Cycle | 6 | 2022 | 2918 | 0.550 |
Why?
|
| Cerebellar Neoplasms | 3 | 2019 | 571 | 0.550 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2015 | 3794 | 0.540 |
Why?
|
| Gene Rearrangement | 11 | 2020 | 1143 | 0.510 |
Why?
|
| Proto-Oncogenes | 1 | 2016 | 320 | 0.480 |
Why?
|
| Publications | 1 | 2017 | 195 | 0.480 |
Why?
|
| Neurogenesis | 2 | 2019 | 865 | 0.470 |
Why?
|
| Neoplasm Proteins | 7 | 2020 | 3593 | 0.460 |
Why?
|
| Phosphatidylinositol 3-Kinases | 12 | 2018 | 2878 | 0.450 |
Why?
|
| DNA Mutational Analysis | 15 | 2020 | 4106 | 0.450 |
Why?
|
| Gene Expression Profiling | 23 | 2019 | 9522 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2018 | 2454 | 0.450 |
Why?
|
| DNA Methylation | 9 | 2021 | 4425 | 0.450 |
Why?
|
| Stomach Neoplasms | 4 | 2020 | 1472 | 0.430 |
Why?
|
| Cell Lineage | 8 | 2023 | 2573 | 0.430 |
Why?
|
| Humans | 215 | 2025 | 765734 | 0.430 |
Why?
|
| Translocation, Genetic | 3 | 2016 | 1393 | 0.430 |
Why?
|
| Sequence Analysis, DNA | 10 | 2020 | 4772 | 0.430 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2019 | 2051 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2018 | 3169 | 0.410 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2022 | 2941 | 0.410 |
Why?
|
| RNA-Binding Proteins | 6 | 2025 | 1876 | 0.410 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 658 | 0.400 |
Why?
|
| Endometrial Neoplasms | 7 | 2018 | 1378 | 0.400 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 385 | 0.390 |
Why?
|
| MicroRNAs | 7 | 2021 | 3784 | 0.390 |
Why?
|
| Kidney Neoplasms | 8 | 2021 | 4262 | 0.380 |
Why?
|
| Polymorphism, Single Nucleotide | 27 | 2021 | 16041 | 0.370 |
Why?
|
| Phosphoproteins | 3 | 2020 | 2445 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2021 | 5336 | 0.370 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2018 | 1365 | 0.360 |
Why?
|
| Publishing | 1 | 2017 | 835 | 0.340 |
Why?
|
| Germ-Line Mutation | 4 | 2024 | 1883 | 0.340 |
Why?
|
| Neoplasm Recurrence, Local | 11 | 2024 | 9368 | 0.340 |
Why?
|
| Carcinoma, Medullary | 2 | 2021 | 114 | 0.330 |
Why?
|
| Oncogene Proteins, Fusion | 7 | 2021 | 1608 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2023 | 451 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2020 | 2896 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2019 | 994 | 0.310 |
Why?
|
| Computational Biology | 6 | 2021 | 3558 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2014 | 1241 | 0.310 |
Why?
|
| PTEN Phosphohydrolase | 9 | 2018 | 1118 | 0.300 |
Why?
|
| Nuclear Proteins | 12 | 2024 | 5781 | 0.300 |
Why?
|
| bcl-X Protein | 4 | 2016 | 414 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2021 | 18061 | 0.300 |
Why?
|
| Comparative Genomic Hybridization | 9 | 2017 | 474 | 0.300 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2009 | 154 | 0.290 |
Why?
|
| Adenocarcinoma | 7 | 2020 | 6356 | 0.290 |
Why?
|
| Genomic Instability | 4 | 2019 | 718 | 0.290 |
Why?
|
| Histones | 7 | 2024 | 2592 | 0.290 |
Why?
|
| DNA, Neoplasm | 11 | 2021 | 1740 | 0.280 |
Why?
|
| Transcription Factors | 15 | 2024 | 12123 | 0.280 |
Why?
|
| Alleles | 8 | 2021 | 6893 | 0.270 |
Why?
|
| Oligodendroglia | 3 | 2020 | 543 | 0.270 |
Why?
|
| Cell Proliferation | 19 | 2021 | 10428 | 0.270 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2020 | 303 | 0.260 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 3 | 2020 | 367 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2018 | 2794 | 0.260 |
Why?
|
| Hedgehog Proteins | 4 | 2014 | 772 | 0.260 |
Why?
|
| Proteins | 3 | 2019 | 5996 | 0.250 |
Why?
|
| Genetic Heterogeneity | 5 | 2021 | 735 | 0.250 |
Why?
|
| Genes, Neoplasm | 5 | 2018 | 370 | 0.250 |
Why?
|
| Epigenesis, Genetic | 9 | 2020 | 3818 | 0.250 |
Why?
|
| Signal Transduction | 32 | 2020 | 23589 | 0.240 |
Why?
|
| Genome | 3 | 2021 | 1752 | 0.240 |
Why?
|
| Models, Genetic | 6 | 2021 | 3447 | 0.240 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2019 | 2046 | 0.240 |
Why?
|
| Databases, Genetic | 7 | 2021 | 1751 | 0.240 |
Why?
|
| Transcription, Genetic | 10 | 2021 | 7599 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2016 | 285 | 0.230 |
Why?
|
| MAP Kinase Signaling System | 3 | 2019 | 1489 | 0.230 |
Why?
|
| DNA-Binding Proteins | 10 | 2020 | 9594 | 0.230 |
Why?
|
| Genes, p53 | 4 | 2015 | 709 | 0.230 |
Why?
|
| Mice | 41 | 2023 | 81792 | 0.230 |
Why?
|
| Mice, Nude | 13 | 2019 | 3614 | 0.230 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2018 | 1761 | 0.220 |
Why?
|
| In Situ Hybridization, Fluorescence | 11 | 2019 | 2504 | 0.220 |
Why?
|
| Pituitary Neoplasms | 3 | 2017 | 1322 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2019 | 561 | 0.220 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2019 | 1138 | 0.210 |
Why?
|
| Chromatin | 4 | 2020 | 2981 | 0.210 |
Why?
|
| Jaundice, Neonatal | 1 | 2003 | 70 | 0.210 |
Why?
|
| Gene Fusion | 4 | 2016 | 356 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 386 | 0.200 |
Why?
|
| Thyrotoxicosis | 1 | 2003 | 85 | 0.200 |
Why?
|
| Neuroblastoma | 2 | 2022 | 1263 | 0.200 |
Why?
|
| Centromere | 1 | 2023 | 213 | 0.200 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2022 | 43 | 0.200 |
Why?
|
| Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2018 | 904 | 0.200 |
Why?
|
| Esophageal Neoplasms | 5 | 2020 | 1661 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2022 | 4520 | 0.200 |
Why?
|
| Haplotypes | 4 | 2021 | 2728 | 0.190 |
Why?
|
| Cell Cycle Proteins | 8 | 2024 | 3431 | 0.190 |
Why?
|
| Prostatic Neoplasms | 10 | 2010 | 11080 | 0.190 |
Why?
|
| Animals | 49 | 2023 | 168731 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2019 | 1314 | 0.190 |
Why?
|
| Graves Disease | 1 | 2003 | 240 | 0.190 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 2013 | 95 | 0.190 |
Why?
|
| Dacarbazine | 2 | 2015 | 552 | 0.180 |
Why?
|
| Trans-Activators | 5 | 2013 | 2850 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 6 | 2019 | 2822 | 0.180 |
Why?
|
| Neoplasm Metastasis | 9 | 2018 | 4885 | 0.180 |
Why?
|
| Apoptosis | 9 | 2020 | 9511 | 0.180 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 453 | 0.180 |
Why?
|
| Cloning, Organism | 1 | 2020 | 50 | 0.180 |
Why?
|
| Tachykinins | 1 | 2021 | 78 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 2 | 2024 | 2895 | 0.180 |
Why?
|
| S Phase | 2 | 2019 | 424 | 0.170 |
Why?
|
| Peptide Nucleic Acids | 1 | 2020 | 28 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 3605 | 0.170 |
Why?
|
| Neoplasm Transplantation | 8 | 2019 | 2011 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 8 | 2018 | 3595 | 0.170 |
Why?
|
| DNA Primase | 1 | 2020 | 110 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2019 | 640 | 0.160 |
Why?
|
| Genetic Variation | 6 | 2024 | 6607 | 0.160 |
Why?
|
| Cyclin D2 | 1 | 2019 | 97 | 0.160 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.160 |
Why?
|
| Telomere | 2 | 2023 | 941 | 0.160 |
Why?
|
| Gene Deletion | 9 | 2020 | 2666 | 0.160 |
Why?
|
| Cluster Analysis | 6 | 2016 | 2720 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2019 | 6109 | 0.160 |
Why?
|
| Melanoma | 5 | 2022 | 5690 | 0.160 |
Why?
|
| Retroelements | 1 | 2020 | 163 | 0.150 |
Why?
|
| Algorithms | 10 | 2022 | 14061 | 0.150 |
Why?
|
| Telomerase | 4 | 2020 | 749 | 0.150 |
Why?
|
| Female | 69 | 2025 | 395961 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 69 | 0.150 |
Why?
|
| Phenotype | 12 | 2021 | 16706 | 0.150 |
Why?
|
| Genes, myc | 3 | 2018 | 392 | 0.150 |
Why?
|
| Antineoplastic Agents | 9 | 2019 | 13639 | 0.150 |
Why?
|
| Chromosome Deletion | 7 | 2018 | 1385 | 0.150 |
Why?
|
| Male | 63 | 2025 | 363585 | 0.150 |
Why?
|
| Lung Neoplasms | 9 | 2025 | 13448 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 124 | 0.150 |
Why?
|
| Quinazolines | 4 | 2015 | 1365 | 0.150 |
Why?
|
| Interleukin-9 | 1 | 2018 | 63 | 0.150 |
Why?
|
| Receptors, Androgen | 2 | 2018 | 1087 | 0.150 |
Why?
|
| Morpholines | 2 | 2019 | 577 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2018 | 322 | 0.150 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2020 | 332 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2023 | 5693 | 0.140 |
Why?
|
| Pyridazines | 1 | 2019 | 200 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2016 | 1892 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2013 | 697 | 0.140 |
Why?
|
| Salvage Therapy | 2 | 2014 | 1272 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 352 | 0.140 |
Why?
|
| RNA, Neoplasm | 3 | 2016 | 745 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2020 | 462 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 225 | 0.140 |
Why?
|
| Aminopyridines | 2 | 2019 | 576 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 455 | 0.140 |
Why?
|
| Cell Survival | 8 | 2020 | 5747 | 0.140 |
Why?
|
| RNA Interference | 7 | 2019 | 2828 | 0.140 |
Why?
|
| Indazoles | 1 | 2018 | 303 | 0.140 |
Why?
|
| ras Proteins | 4 | 2015 | 1053 | 0.140 |
Why?
|
| Urothelium | 1 | 2019 | 272 | 0.140 |
Why?
|
| DNA Repair | 4 | 2024 | 2051 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2020 | 798 | 0.130 |
Why?
|
| Neoplasms, Second Primary | 2 | 2022 | 1048 | 0.130 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.130 |
Why?
|
| RNA, Small Interfering | 7 | 2014 | 3419 | 0.130 |
Why?
|
| Prognosis | 13 | 2025 | 29899 | 0.130 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 158 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2020 | 702 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 1105 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 129 | 0.130 |
Why?
|
| Chromosomes, Human | 2 | 2016 | 437 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2019 | 328 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 1240 | 0.130 |
Why?
|
| Cyclin E | 2 | 2014 | 155 | 0.130 |
Why?
|
| Ear Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
| Ploidies | 2 | 2013 | 287 | 0.130 |
Why?
|
| Virus Integration | 1 | 2018 | 303 | 0.130 |
Why?
|
| Interneurons | 1 | 2020 | 593 | 0.130 |
Why?
|
| Receptor, trkB | 1 | 2016 | 122 | 0.120 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 197 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2015 | 385 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2020 | 700 | 0.120 |
Why?
|
| Disease Progression | 14 | 2019 | 13614 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 370 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2017 | 2171 | 0.120 |
Why?
|
| Disease-Free Survival | 8 | 2018 | 6832 | 0.120 |
Why?
|
| Endometrial Hyperplasia | 1 | 2016 | 101 | 0.120 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2018 | 1434 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 5 | 2025 | 954 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 634 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2016 | 271 | 0.120 |
Why?
|
| Oncogene Proteins | 3 | 2014 | 710 | 0.120 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 209 | 0.120 |
Why?
|
| Documentation | 1 | 2021 | 916 | 0.120 |
Why?
|
| Ovarian Neoplasms | 6 | 2014 | 4900 | 0.120 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2016 | 146 | 0.120 |
Why?
|
| Oligodendroglioma | 2 | 2014 | 274 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2016 | 284 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 319 | 0.120 |
Why?
|
| Antigens, Bacterial | 1 | 2020 | 1145 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 924 | 0.120 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 276 | 0.120 |
Why?
|
| Cytosine | 1 | 2015 | 212 | 0.110 |
Why?
|
| Vestibule, Labyrinth | 1 | 2016 | 234 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 229 | 0.110 |
Why?
|
| Immunohistochemistry | 8 | 2016 | 11007 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1409 | 0.110 |
Why?
|
| Pelvic Neoplasms | 1 | 2016 | 246 | 0.110 |
Why?
|
| Mice, Inbred NOD | 5 | 2020 | 1837 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2020 | 1227 | 0.110 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2020 | 614 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 184 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2015 | 561 | 0.110 |
Why?
|
| Chromosome Mapping | 4 | 2016 | 4618 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 2137 | 0.110 |
Why?
|
| DNA Damage | 3 | 2025 | 2461 | 0.110 |
Why?
|
| Genome-Wide Association Study | 6 | 2020 | 12800 | 0.110 |
Why?
|
| Astrocytes | 3 | 2020 | 1345 | 0.110 |
Why?
|
| Child | 18 | 2025 | 80499 | 0.110 |
Why?
|
| Chromosomes | 1 | 2017 | 578 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2022 | 2880 | 0.110 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 23 | 0.110 |
Why?
|
| Semantics | 1 | 2017 | 609 | 0.110 |
Why?
|
| Adult | 35 | 2025 | 222974 | 0.110 |
Why?
|
| Imidazoles | 1 | 2019 | 1163 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 72 | 0.110 |
Why?
|
| Breast Neoplasms | 10 | 2025 | 21053 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2020 | 974 | 0.100 |
Why?
|
| Aged | 32 | 2025 | 171050 | 0.100 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 125 | 0.100 |
Why?
|
| Middle Aged | 36 | 2025 | 222903 | 0.100 |
Why?
|
| Ependymoma | 1 | 2016 | 310 | 0.100 |
Why?
|
| Piperidines | 3 | 2018 | 1663 | 0.100 |
Why?
|
| Oncogenic Viruses | 1 | 2012 | 37 | 0.100 |
Why?
|
| Somatostatin | 1 | 2014 | 459 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 415 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2016 | 1749 | 0.100 |
Why?
|
| Chromosome Breakage | 1 | 2012 | 159 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 260 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2014 | 449 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 228 | 0.100 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 483 | 0.100 |
Why?
|
| Genetic Techniques | 2 | 2012 | 429 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2740 | 0.100 |
Why?
|
| Survival Analysis | 5 | 2018 | 10069 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2020 | 3159 | 0.100 |
Why?
|
| Neurofibromin 1 | 2 | 2012 | 189 | 0.090 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 480 | 0.090 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 268 | 0.090 |
Why?
|
| Probability | 2 | 2007 | 2473 | 0.090 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.090 |
Why?
|
| Microsatellite Repeats | 2 | 2020 | 784 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2014 | 3592 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2011 | 53 | 0.090 |
Why?
|
| Neurilemmoma | 1 | 2016 | 522 | 0.090 |
Why?
|
| Clone Cells | 3 | 2020 | 1672 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 2007 | 6061 | 0.090 |
Why?
|
| DNA Breaks | 2 | 2021 | 48 | 0.090 |
Why?
|
| Cerebrum | 1 | 2012 | 132 | 0.090 |
Why?
|
| Trisomy | 1 | 2012 | 259 | 0.090 |
Why?
|
| Biotechnology | 2 | 2012 | 284 | 0.090 |
Why?
|
| RNA | 1 | 2020 | 2717 | 0.090 |
Why?
|
| Parietal Lobe | 1 | 2016 | 859 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 833 | 0.090 |
Why?
|
| Open Reading Frames | 3 | 2025 | 820 | 0.090 |
Why?
|
| Multigene Family | 2 | 2013 | 1081 | 0.090 |
Why?
|
| Dogs | 1 | 2015 | 3822 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 1959 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 488 | 0.090 |
Why?
|
| Stathmin | 1 | 2010 | 68 | 0.090 |
Why?
|
| Microglia | 1 | 2019 | 1371 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 782 | 0.090 |
Why?
|
| Genes, ras | 2 | 2010 | 657 | 0.090 |
Why?
|
| Survival Rate | 7 | 2025 | 12787 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 5787 | 0.090 |
Why?
|
| Carrier Proteins | 4 | 2021 | 4912 | 0.090 |
Why?
|
| Serine Endopeptidases | 3 | 2016 | 1024 | 0.090 |
Why?
|
| Virology | 1 | 2010 | 77 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 334 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 708 | 0.080 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 54 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 469 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11865 | 0.080 |
Why?
|
| Malformations of Cortical Development | 1 | 2012 | 174 | 0.080 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 18289 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 594 | 0.080 |
Why?
|
| Receptors, HIV | 1 | 2010 | 159 | 0.080 |
Why?
|
| Base Sequence | 4 | 2014 | 12402 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 4 | 2019 | 2036 | 0.080 |
Why?
|
| Germ Cells | 2 | 2024 | 646 | 0.080 |
Why?
|
| DNA Helicases | 3 | 2024 | 852 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 855 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 2969 | 0.080 |
Why?
|
| Models, Biological | 4 | 2020 | 9441 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2018 | 1981 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2014 | 1775 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 191 | 0.080 |
Why?
|
| Protein Binding | 6 | 2021 | 9299 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 632 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 4038 | 0.080 |
Why?
|
| Mice, SCID | 4 | 2016 | 2627 | 0.080 |
Why?
|
| Cohort Studies | 11 | 2024 | 41631 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 943 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 837 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 498 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 378 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2014 | 2486 | 0.080 |
Why?
|
| Gene Frequency | 2 | 2020 | 3623 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2013 | 5388 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 1747 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2009 | 312 | 0.070 |
Why?
|
| Gene Expression | 3 | 2022 | 7584 | 0.070 |
Why?
|
| Child, Preschool | 8 | 2022 | 42468 | 0.070 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 282 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 1525 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2016 | 2968 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 1154 | 0.070 |
Why?
|
| Cranial Irradiation | 1 | 2010 | 384 | 0.070 |
Why?
|
| DNA Repair Enzymes | 2 | 2024 | 342 | 0.070 |
Why?
|
| beta Catenin | 1 | 2012 | 1042 | 0.070 |
Why?
|
| Liposarcoma | 1 | 2010 | 288 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 1029 | 0.070 |
Why?
|
| Karnofsky Performance Status | 2 | 2019 | 163 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 618 | 0.070 |
Why?
|
| Young Adult | 13 | 2025 | 59852 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2016 | 917 | 0.070 |
Why?
|
| Oxygen | 1 | 2019 | 4242 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 838 | 0.070 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 381 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 2 | 2020 | 661 | 0.070 |
Why?
|
| Cholangiocarcinoma | 1 | 2013 | 578 | 0.070 |
Why?
|
| Aged, 80 and over | 14 | 2019 | 59459 | 0.070 |
Why?
|
| Survivors | 2 | 2014 | 2374 | 0.070 |
Why?
|
| Seizures | 2 | 2024 | 2999 | 0.070 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3948 | 0.070 |
Why?
|
| Adenoma | 1 | 2017 | 2152 | 0.070 |
Why?
|
| Indoles | 1 | 2015 | 1832 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2019 | 2175 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2019 | 350 | 0.070 |
Why?
|
| Retrospective Studies | 13 | 2025 | 81457 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 6499 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 1533 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2010 | 502 | 0.070 |
Why?
|
| Colonic Neoplasms | 3 | 2012 | 2531 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2022 | 1511 | 0.060 |
Why?
|
| Adolescent | 11 | 2025 | 88781 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2008 | 1082 | 0.060 |
Why?
|
| Saposins | 1 | 2005 | 22 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 723 | 0.060 |
Why?
|
| src-Family Kinases | 3 | 2015 | 538 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 8038 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3691 | 0.060 |
Why?
|
| DNA Modification Methylases | 2 | 2018 | 207 | 0.060 |
Why?
|
| Transplantation, Heterologous | 4 | 2017 | 2393 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2022 | 4255 | 0.060 |
Why?
|
| Neoplasms, Experimental | 3 | 2020 | 1229 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2012 | 1798 | 0.060 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2018 | 660 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 163 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2019 | 3585 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2015 | 1855 | 0.060 |
Why?
|
| Genotype | 7 | 2021 | 13024 | 0.060 |
Why?
|
| Bacillus Phages | 1 | 2004 | 12 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 961 | 0.060 |
Why?
|
| Gene Duplication | 2 | 2018 | 317 | 0.060 |
Why?
|
| Neurofibromatosis 1 | 1 | 2009 | 560 | 0.060 |
Why?
|
| DNA | 2 | 2021 | 7200 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 1461 | 0.050 |
Why?
|
| Infant | 5 | 2022 | 36363 | 0.050 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 17595 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2022 | 12769 | 0.050 |
Why?
|
| Cell Line | 5 | 2024 | 15542 | 0.050 |
Why?
|
| False Negative Reactions | 1 | 2024 | 568 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
| Combined Modality Therapy | 4 | 2018 | 8528 | 0.050 |
Why?
|
| raf Kinases | 2 | 2016 | 116 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2354 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2020 | 14445 | 0.050 |
Why?
|
| Treatment Outcome | 6 | 2024 | 65180 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 2423 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 4 | 2013 | 3751 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14745 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2586 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 433 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2014 | 506 | 0.050 |
Why?
|
| Androgens | 2 | 2009 | 1278 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2685 | 0.050 |
Why?
|
| Proteomics | 1 | 2015 | 3910 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 482 | 0.050 |
Why?
|
| Radiosurgery | 1 | 2010 | 1328 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 39180 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2022 | 327 | 0.040 |
Why?
|
| Diploidy | 1 | 2021 | 141 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2014 | 384 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2020 | 1505 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2021 | 224 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2020 | 30 | 0.040 |
Why?
|
| Chromosome Inversion | 1 | 2020 | 119 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26332 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 2657 | 0.040 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 352 | 0.040 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2020 | 98 | 0.040 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 192 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2649 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 2013 | 1080 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2021 | 229 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 14637 | 0.040 |
Why?
|
| NIH 3T3 Cells | 2 | 2014 | 651 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 360 | 0.040 |
Why?
|
| Kidney | 2 | 2019 | 7066 | 0.040 |
Why?
|
| Glucose | 1 | 2011 | 4334 | 0.040 |
Why?
|
| Succinate Dehydrogenase | 1 | 2020 | 148 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2013 | 4352 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2020 | 144 | 0.040 |
Why?
|
| Pyridines | 3 | 2018 | 2889 | 0.040 |
Why?
|
| Nervous System | 1 | 2022 | 542 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 329 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1801 | 0.040 |
Why?
|
| Mammary Glands, Human | 2 | 2013 | 199 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2393 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 339 | 0.040 |
Why?
|
| Receptor, TIE-2 | 1 | 2019 | 183 | 0.040 |
Why?
|
| Phylogeny | 2 | 2016 | 2836 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2014 | 6598 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
| Tissue Array Analysis | 2 | 2010 | 544 | 0.040 |
Why?
|
| Biphenyl Compounds | 2 | 2014 | 1020 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2012 | 627 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2018 | 2056 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2015 | 11201 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2019 | 189 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2020 | 18972 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.040 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 169 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2011 | 5019 | 0.040 |
Why?
|
| Streptococcus pyogenes | 1 | 2020 | 295 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 36537 | 0.040 |
Why?
|
| Receptors, Cell Surface | 3 | 2014 | 2817 | 0.030 |
Why?
|
| Cell Shape | 1 | 2018 | 372 | 0.030 |
Why?
|
| Zebrafish | 3 | 2014 | 3034 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 2592 | 0.030 |
Why?
|
| Binding Sites | 2 | 2021 | 6001 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 562 | 0.030 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 433 | 0.030 |
Why?
|
| Pyrimidines | 3 | 2018 | 3044 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2024 | 4752 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2015 | 5381 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2019 | 548 | 0.030 |
Why?
|
| Chromogranins | 1 | 2017 | 160 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2019 | 646 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 605 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 714 | 0.030 |
Why?
|
| Methylation | 1 | 2019 | 1075 | 0.030 |
Why?
|
| Cell Division | 3 | 2009 | 4472 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12509 | 0.030 |
Why?
|
| Lysine | 1 | 2020 | 992 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 561 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4563 | 0.030 |
Why?
|
| World Health Organization | 1 | 2022 | 1327 | 0.030 |
Why?
|
| Barrett Esophagus | 1 | 2020 | 494 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2015 | 38 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2016 | 220 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 1885 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2018 | 384 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2015 | 8279 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2011 | 4862 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2016 | 206 | 0.030 |
Why?
|
| Cell Movement | 3 | 2014 | 5192 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 801 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10806 | 0.030 |
Why?
|
| Anilides | 1 | 2018 | 415 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 146 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2016 | 252 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 353 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20120 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 298 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1352 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2015 | 122 | 0.030 |
Why?
|
| Lomustine | 1 | 2014 | 60 | 0.030 |
Why?
|
| Carmustine | 1 | 2014 | 137 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15390 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2017 | 591 | 0.030 |
Why?
|
| Stem Cells | 1 | 2007 | 3539 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2019 | 839 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2015 | 199 | 0.030 |
Why?
|
| Homozygote | 2 | 2012 | 1774 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 138 | 0.030 |
Why?
|
| Teratoma | 1 | 2016 | 401 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 739 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 9548 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2010 | 1743 | 0.030 |
Why?
|
| Mitochondria | 2 | 2016 | 3670 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2012 | 17 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 722 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 203 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 2406 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 938 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2017 | 878 | 0.030 |
Why?
|
| G1 Phase | 1 | 2014 | 403 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 93 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6944 | 0.030 |
Why?
|
| Pyridones | 1 | 2018 | 816 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 93 | 0.030 |
Why?
|
| Hemizygote | 1 | 2012 | 27 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 104 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 42 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2013 | 200 | 0.030 |
Why?
|
| Exosomes | 1 | 2017 | 421 | 0.030 |
Why?
|
| Base Composition | 1 | 2012 | 291 | 0.020 |
Why?
|
| Obesity | 1 | 2015 | 13079 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2014 | 898 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2012 | 157 | 0.020 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2012 | 70 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 2 | 2012 | 1994 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2012 | 269 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2017 | 1160 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2012 | 201 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22321 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 3717 | 0.020 |
Why?
|
| Polyomavirus | 1 | 2012 | 236 | 0.020 |
Why?
|
| Time Factors | 3 | 2021 | 40066 | 0.020 |
Why?
|
| Vietnam | 1 | 2012 | 411 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 1151 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2012 | 463 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 307 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 990 | 0.020 |
Why?
|
| CpG Islands | 1 | 2015 | 1207 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2015 | 1718 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 1947 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 619 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 786 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 938 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 4391 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2015 | 1107 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 465 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3537 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2015 | 1009 | 0.020 |
Why?
|
| SEER Program | 1 | 2015 | 1444 | 0.020 |
Why?
|
| Transfection | 2 | 2009 | 5744 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1696 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 770 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 287 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 778 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1643 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2012 | 624 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1884 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3200 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2009 | 45 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
| Nevus | 1 | 2011 | 203 | 0.020 |
Why?
|
| Blister | 1 | 2009 | 88 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 166 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2207 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2631 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2391 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1193 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 2462 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 713 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2009 | 196 | 0.020 |
Why?
|
| Platelet Count | 1 | 2011 | 782 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2019 | 3504 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3067 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 856 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 751 | 0.020 |
Why?
|
| Blood Coagulation Factors | 1 | 2010 | 371 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 1092 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2016 | 1783 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2012 | 6252 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1617 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 3946 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1544 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2012 | 752 | 0.020 |
Why?
|
| Melanocytes | 1 | 2011 | 503 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 3273 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 274 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 8498 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 2013 | 625 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1936 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2009 | 332 | 0.020 |
Why?
|
| Point Mutation | 1 | 2012 | 1590 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2012 | 1078 | 0.020 |
Why?
|
| Cell Separation | 1 | 2012 | 1718 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 741 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1739 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2538 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6203 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2011 | 1865 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1525 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2012 | 1137 | 0.020 |
Why?
|
| Incidence | 2 | 2015 | 21478 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1558 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2025 | 54795 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 1432 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 74831 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 612 | 0.020 |
Why?
|
| Pregnancy | 2 | 2007 | 30248 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2005 | 160 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1752 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 2273 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2006 | 255 | 0.010 |
Why?
|
| Genes, erbB-1 | 1 | 2005 | 161 | 0.010 |
Why?
|
| DNA Primers | 1 | 2009 | 2823 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4542 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6307 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2009 | 1202 | 0.010 |
Why?
|
| Colon | 1 | 2012 | 1795 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 682 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7424 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2081 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3451 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1332 | 0.010 |
Why?
|
| Age of Onset | 1 | 2011 | 3339 | 0.010 |
Why?
|
| HIV Infections | 1 | 2010 | 17531 | 0.010 |
Why?
|
| Proteome | 1 | 2013 | 1897 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2025 | 24279 | 0.010 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2005 | 257 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2005 | 752 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2004 | 416 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 1306 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2004 | 455 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4779 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2926 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8732 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5879 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 1066 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 6207 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1529 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10730 | 0.010 |
Why?
|
| Internet | 1 | 2012 | 3103 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2004 | 931 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 4165 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1998 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 1600 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12949 | 0.010 |
Why?
|
| Risk | 1 | 2011 | 9592 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2011 | 3461 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3563 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3604 | 0.010 |
Why?
|
| Carcinoma in Situ | 1 | 2004 | 776 | 0.010 |
Why?
|
| Age Factors | 1 | 2015 | 18375 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10262 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 2598 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8062 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2015 | 13044 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 2328 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3318 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 4020 | 0.010 |
Why?
|
| Breast | 1 | 2004 | 1946 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7849 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 11641 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9245 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15648 | 0.000 |
Why?
|
| Brain | 1 | 2014 | 27178 | 0.000 |
Why?
|